Investigación

Enfermedades Infecciosas y Microbioma

Buscador de publicaciones

Publicaciones

  • Ciruela Navas P, Soldevila N, García-García JJ, González-Peris S, Álvaro Díaz Conradi, Redin-Alonso A, Viñado B, Izquierdo C, Munoz-Almagro C, Domínguez A, Campins M, Esteva-Afonso C, Fernández de Sevilla-Estrach M, Fernando Moraga Llop and Salleras Ll.

    Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain

    EMERGING INFECTIOUS DISEASES . 28(11): 2321-2325. Nº de citas: 10

    [doi:10.3201/eid2811.211741]

  • Sánchez-Manubens J, Henares-Bonilla D, Munoz-Almagro C, Brotons-de los Reyes P, Timoneda-Sole N and Anton-Lopez J.

    Characterization of the nasopharyngeal microbiome in patients with Kawasaki disease

    anales de pediatria . 97(5): 300-309. Nº de citas: 1

    [doi:10.1016/j.anpedi.2021.11.010]

  • Santos Bravo M, Plault N, Sánchez-Palomino S, Rodríguez C, Navarro Gabriel M, Mosquera MM, Fernández Avilés F, Suarez-Lledó M, Rovira M, Bodro M, Moreno A, Linares L, Cofan F, Berengua C, Esteva-Afonso C, Cordero E, Martin-Davila P, Aranzamendi M, Pérez Jiménez AB, Vidal E, Fernández Sabé N, Len O, Hantz S, Alain S and Marcos MÁ.

    Genotypic and Phenotypic Study of Antiviral Resistance Mutations in Refractory Cytomegalovirus Infection

    JOURNAL OF INFECTIOUS DISEASES . 226(9): 1528-1536. Nº de citas: 5

    [doi:10.1093/infdis/jiac349]

  • Merdrignac L, Acosta L, Habington A, Garcìa Cenoz M, Pandolfi E, Fabiánová K, Jordán-García I, O'Sullivan N, Navasués A, Tozzi AE, Zavadilová J, Jané M, Cotter S, Pitillas NI, Rizzo C, Krížová P, Hanslik T, Munoz-Almagro C, Pastore L, Bacci S, Moren A and Valenciano M.

    Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother?s vaccination in pregnancy in infants aged 2-11 months

    Vaccine . 40(44): 6374-6382. Nº de citas: 18

    [doi:10.1016/j.vaccine.2022.09.054]

  • Goncé A, Hawkins-Villarreal A, Salazar L, Guirado L, Marcos MA, Pascual Mancho J, Prats P, López M, Eixarch E, Salvia MD, Fortuny-Guasch C and Figueras-Retuerta F.

    Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection

    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE . 35(20): 4004-4008. Nº de citas: 6

    [doi:10.1080/14767058.2020.1843016]

  • Lo SW, Mellor K, Cohen R, Redin-Alonso A, Belman S, Kumar N, Hawkins PA, Gladstone RA, von Gottberg A, Veeraraghavan B, Ravikumar KL, Kandasamy R, Pollard SAJ, Saha SK, Bigogo G, Antonio M, Kwambana-Adams B, Mirza S, Shakoor S, Nisar I, Cornick JE, Lehmann D, Ford RL, Sigauque B, Turner P, Moïsi J, Obaro SK, Dagan R, Diawara I, Skoczynska A, Wang H, Carter PE, Klugman KP, Rodgers G, Breiman RF, McGee L, Bentley SD, Munoz-Almagro C and Varon E.

    Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study

    Lancet Microbe . 3(10): 735-743. Nº de citas: 40

    [doi:10.1016/S2666-5247(22)00158-6]

  • Aguilera-Alonso, D, Solis-Garcia, G, Noguera-Julian A, Gonzalez-Martin, J, Cobena, AR, Baquero-Artigao, F, Rueda, CT, Rodriguez-Molino, P, Sanchez, IB, Vallmanya, T, Bernet-Sanchez, A, Domingo, LM, Rubio, A, Saavedra-Lozano, J, Ruiz-Serrano, MJ, Blazquez-Gamero, D, Lopez-Roa, P, Gomez-Pastrana, D, Prieto, MDL, Medina, EML, Gil-Brusola, A, Nalda, AM, Soriano-Arandes, A, Tortola, T, Falcon-Neyra, L, Galan, VG, Tebruegge, M and Santiago-Garcia, B.

    Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

    Thorax . 77(10): 1023-1029. Nº de citas: 9

    [doi:10.1136/thorax-2021-218378]

  • Torres-Fernandez D, Jiménez de Ory S, Fortuny-Guasch C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á and Prieto L.

    Integrase inhibitors in children and adolescents: clinical use and resistance

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(10): 2784-2792. Nº de citas: 3

    [doi:10.1093/jac/dkac259]

  • Turkova A, Waalewijn H, Chan MK, Bollen PDJ, Bwakura-Dangarembizi MF, Kekitiinwa AR, Cotton MF, Lugemwa A, Variava E, Ahimbisibwe GM, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo CM, Archary M, Ferrand RA, Violari A, Gibb DM, Burger DM, Ford D and Colbers A.

    Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

    Lancet HIV . 9(9): 627-637. Nº de citas: 17

    [doi:10.1016/S2352-3018(22)00160-6]

  • Amuge P, Lugemwa A, Wynne B, Mujuru HA, Violari A, Kityo CM, Archary M, Variava E, White E, Turner RM, Shakeshaft C, Ali S, Nathoo KJ, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa AR, Giaquinto C, Rojo P, Gibb DM, Turkova A and Ford D.

    Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

    Lancet HIV . 9(9): 638-648. Nº de citas: 17

    [doi:10.1016/S2352-3018(22)00163-1]